This is an old revision of the document!
AstraZeneca
COVID-19
AstraZeneca is distributing a viral vector-based COVID-19 vaccine product in Canada and other countries called ChAdOx1 nCoV-19. It is marketed in Canada as Vaxzevria.1)
Affiliations
AstraZeneca is a member organization of the World Economic Forum.2)
Acquisitions
Payments from AstraZeneca
The following is a developing list of individuals and organizations that AstraZeneca has given money to related to the COVID-19 pandemic:
Payments to Individuals
| Name | Type | Amount | Description |
|---|---|---|---|
| David Fisman | Honorarium | Unknown | Honorarium paid for advisory board meetings regarding COVID-19 related projects.4) |
Payments to Organizations
| Name | Type | Amount | Description |
|---|---|---|---|
| St. Michaels Hospital Foundation | Donations | $1,000,000.00 - $2,499,999.00 |
1)
Health Canada. (2021, November 23). AstraZeneca Vaxzevria COVID-19 vaccine. Government of Canada. Retrieved December 5, 2021, from https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/astrazeneca.html
2)
AstraZeneca. (2021, December 3). World Economic Forum. https://archive.ph/CV1XD
3)
Kemp, A. (2021, July 21). Acquisition of Alexion completed. AstraZeneca. https://archive.ph/c5apv
4)
Fisman, D. (2021). Declaration of Interest. Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/10/Declaration-of-Interest_Science-Table_David-Fisman2.pdf